Loading...
Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARB) Are Protective Against ICU Admission and Mortality for Patients With COVID-19 Disease
Introduction: Corona Virus disease 2019 (COVID-19) caused by the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) has become a global pandemic. The aim of this study was to investigate the impact of being on an Angiotensin-Converting Enzyme Inhibitors (ACEI) and/or Angiotensin Receptor B...
Na minha lista:
| Udgivet i: | Front Med (Lausanne) |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7969499/ https://ncbi.nlm.nih.gov/pubmed/33748156 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2021.600385 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|